Here's the live share price of Anthem Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Anthem Biosciences has declined 0.09% CAGR. Over the past year, the corresponding return has been -0.44%.
Anthem Biosciences’s current P/E of 0.00x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Anthem Biosciences | -5.86 | -12.41 | -0.44 | -0.44 | -0.44 | -0.15 | -0.09 |
Sun Pharmaceutical Industries | 2.09 | 2.71 | -0.18 | -3.19 | -10.96 | 19.95 | 28.41 |
Divi's Laboratories | 0.91 | 8.64 | -1.07 | 12.4 | 11.73 | 22.83 | 16.43 |
Cipla | 5.55 | 6.33 | 11.1 | 8.46 | 7.64 | 13.36 | 16.5 |
Torrent Pharmaceuticals | 1.42 | -2.32 | 1.28 | 9.69 | 5.2 | 31.71 | 21.7 |
Dr. Reddy's Laboratories | 3.65 | -1.47 | 1.82 | 8.94 | -4.24 | 13.73 | 4.89 |
Mankind Pharma | 0.74 | -5.48 | -7.28 | -5.02 | -7.08 | 19.89 | 11.5 |
Zydus Lifesciences | 2.35 | -3.22 | 3.34 | 18.56 | -0.3 | 34.15 | 18.86 |
Lupin | 0.22 | -3.17 | 1.06 | -3.34 | -9.64 | 40.95 | 13.88 |
Alkem Laboratories | 1.11 | 1.09 | 11.16 | 11 | -9.77 | 21.35 | 15.95 |
Aurobindo Pharma | -2.09 | -1.57 | -3.38 | -8.38 | -24.6 | 28.57 | 6.57 |
Abbott India | -0.66 | -1.01 | -12.19 | -3.21 | 2.49 | 18.04 | 13.57 |
Glenmark Pharmaceuticals | -2.27 | -8.12 | -15.24 | 35.19 | 7.9 | 67.03 | 31.17 |
Laurus Labs | 5.07 | 1.85 | 11.04 | 43.85 | 98.15 | 21.73 | 22.64 |
Biocon | 3.48 | 0.57 | -7.73 | 9.66 | 7.92 | 10.88 | -3.62 |
GlaxoSmithKline Pharmaceuticals | -0.87 | -0.79 | -12.13 | -2.72 | 3.44 | 25.7 | 12.51 |
Cohance Lifesciences | 0.76 | -3.19 | -18.52 | -27.67 | -31.57 | 28.61 | 20.61 |
Ipca Laboratories | -2.57 | -9.11 | -13.33 | -10.73 | -21.24 | 12.27 | 3.95 |
Gland Pharma | 0.23 | -4.69 | -4.42 | 31.34 | 14.7 | -3.72 | 1.1 |
Ajanta Pharma | 1.82 | -4.08 | -12.25 | -9.04 | -22.42 | 24.44 | 18.78 |
Over the last one year, Anthem Biosciences has declined 0.44% compared to peers like Sun Pharmaceutical Industries (-10.96%), Divi's Laboratories (11.73%), Cipla (7.64%). From a 5 year perspective, Anthem Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (28.41%) and Divi's Laboratories (16.43%).
Day | SMA | EMA |
---|---|---|
5 | 781.05 | 769.83 |
10 | 774.86 | 774.92 |
20 | 790.39 | 784.08 |
50 | 800.33 | 787.18 |
100 | 483.09 | 0 |
200 | 241.55 | 0 |
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
36,82,926 | 0.96 | 280.34 | |
22,26,066 | 0.97 | 169.45 | |
21,11,545 | 1.35 | 160.73 | |
16,83,389 | 1.55 | 128.14 | |
16,00,000 | 2.07 | 121.79 | |
14,40,566 | 0.32 | 109.66 | |
12,00,000 | 2.32 | 91.34 | |
10,58,503 | 0.99 | 80.57 | |
10,52,636 | 1.29 | 80.13 | |
10,07,065 | 1.92 | 76.66 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
---|---|
Oct 06, 2025, 10:39 PM IST | Anthem Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Sep 19, 2025, 9:21 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Sep 16, 2025, 2:24 AM IST | Anthem Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
Aug 18, 2025, 9:38 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Aug 14, 2025, 9:27 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Anthem Biosciences Ltd. is a Public Limited Listed company incorporated on 13/06/2006 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is U24233KA2006PLC039703 and registration number is 039703. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 1840.65 Cr. and Equity Capital is Rs. 111.82 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Anthem Biosciences is ₹727.10 as on Oct 20, 2025.
The Anthem Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Anthem Biosciences is ₹40,834.67 Cr as on Oct 20, 2025.
Today’s highest and lowest price of Anthem Biosciences are ₹768.35 and ₹725.05.
The 52-week high/low is the highest and lowest price at which Anthem Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Anthem Biosciences is ₹873.25 and 52-week low of Anthem Biosciences is ₹701.75 as on Oct 20, 2025.
The Anthem Biosciences has shown returns of -3.99% over the past day, -14.95% for the past month, -0.44% over 3 months, -0.44% over 1 year, -0.15% across 3 years, and -0.09% over 5 years.
P/E ratio of and PB ratio of Anthem Biosciences are 0.00 and 16.94 on Oct 20, 2025. While the company gives a dividend yield of 0.00 per annum.